[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:secondary-cns-lymphoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Secondary CNS Lymphoma",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05098613","Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R\u002FR B-NHL Patients",[11],"Phase 1","RECRUITING","2026-08-26T02:16:59.895916Z","2026-07-19T19:36:05.125264Z",[],[]]